The effects of deprenyl on methamphetamine-induced dopamine depletions
- 1 February 1992
- journal article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 89 (1-2) , 123-127
- https://doi.org/10.1007/bf01245358
Abstract
The effects of deprenyl on methamphetamine-induced dopamine depletions were studied in mice. Four SC injections of 12.5 mg/kg of methamphetamine at two-hour intervals caused substantial (72–82%) and longlasting depletions of striatal dopamine. Pretreatment with either 25 or 40 mg/ kg of deprenyl did not significantly alter the magnitude of this depletion. These results indicate that, unlike what is observed following MPTP, there is no protection afforded dopaminergic cells by deprenyl pretreatment in the methamphetamine model of parkinsonism.Keywords
This publication has 12 references indexed in Scilit:
- Methamphetamine-induced neuronal damage: A possible role for free radicalsNeuropharmacology, 1989
- The Effect of Deprenyl (Selegiline) on the Natural History of Parkinson's DiseaseScience, 1989
- Deprenyl in the Treatment of Symptom Fluctuations in Advanced Parkinsonʼs DiseaseClinical Neuropharmacology, 1988
- Increased life expectancy resulting from addition of l-deprenyl to Madopar® treatment in Parkinson's disease: A longterm studyJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeysEuropean Journal of Pharmacology, 1984
- Clinical evaluation of deprenyl (selegiline) in the treatment of Parkinson's diseaseActa Neurologica Scandinavica, 1983
- Deprenyl (selegiline) in the treatment of Parkinson's diseaseActa Neurologica Scandinavica, 1983
- Deprenyl (selegiline) in combination treatment of Parkinson's diseaseActa Neurologica Scandinavica, 1983
- The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenilJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1975